← Leaderboards
Madhu Satya Bajaj
Saint Louis University
$529,316
Attributed
$529,316
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $231K · FY2009–10$250K$187.5K$125K$62.5K$0
'09
'10
Funding mix
By agency
NIH$529,316 · 2
By mechanism
R21$423,500 · 1
K08$105,816 · 1
Top collaborators
No co-investigators on record.
Most similar at Saint Louis University
Same institution · by research overlap
- S Paul Bajaj$6,914,038
- Alireza R. Rezaie$15,516,581
Others in their field
Top investigators on “Protease Inhibitor”
- Constance Ann Benson · University Of California, San Diego$150,461,206
- Robert Turner Schooley · University Of Colorado Denver$48,400,257
- John Damon Chodera · Sloan-Kettering Inst Can Research$40,777,114
- Daniel R Kuritzkes · Brigham And Women'S Hospital$26,572,064
- David Heimbrook · Leidos Biomedical Research, Inc.$26,054,235
- Celia A. Schiffer · Univ Of Massachusetts Med Sch Worcester$24,364,826
Research focus
Protease InhibitorAdverse EffectsCardiac Surgery ProceduresDefectAprotininBaseBinding (Molecular Function)BiochemicalAnimal ModelBlood FlowBlood TransfusionBlood VesselsCanadaCardiacAntifibrinolytic AgentsCardiopulmonary BypassCardiovascular SystemCattleBlood Coagulation DisordersClinical TrialsCoagulation ProcessComparative EfficacyCrystallographyDesign
Grant awards (3)
Efficacy of Kunitz Domain 1 variants of TFPI-2 as novel antifibrinolytic agents$192,500
R21 · FY2010 · HL · contact PI
Efficacy of Kunitz Domain 1 variants of TFPI-2 as novel antifibrinolytic agents$231,000
R21 · FY2009 · HL · contact PI
REGULATION OF TISSUE FACTOR PATHWAY INHIBITOR EXPRESSION$105,816
K08 · FY2000 · HL